BlackRock, Inc.

Position in FATE — Fate Therapeutics Inc

CIK 2012383 New York, NY

Position in FATE

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$12,082,335

+$2,109,383 QoQ

Shares Held

10,068,614

-1.1% QoQ

Ownership

8.64%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 96.28492064548308.ToString("F0")% Shared 0.ToString("F0")% None 3.7150793545169174.ToString("F0")%

Healthcare · as of Mar 31, 2026

BlackRock, Inc. holds $71,871,411,786 across 472 Biotechnology names. FATE ranks #226 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,969,517	$10,703,348,112
2	REGN	Regeneron Pharmaceuticals, Inc.	8,947,735	$6,913,377,962
3	ALNY	Alnylam Pharmaceuticals, Inc.	10,444,908	$3,455,906,700
4	INSM	INSMED Inc	16,678,146	$2,727,210,424
5	INCY	Incyte Corp	18,978,198	$1,786,227,985
6	MRNA	Moderna, Inc.	29,635,876	$1,505,502,491
7	EXEL	Exelixis, Inc.	30,816,309	$1,321,711,486
8	RPRX	Royalty Pharma plc	25,907,745	$1,242,794,517

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,924,566	2,194,284	-78.2%	Shares	Sole	2026-07-08
2026-03-31	$12,082,335	10,068,614	-1.1%	Shares	Sole	2026-05-13
2025-12-31	$9,972,952	10,176,487	-4.7%	Shares	Sole	2026-02-12
2025-09-30	$13,457,712	10,680,727	-1.2%	Shares	Sole	2025-11-12
2025-06-30	$12,107,733	10,810,481	+1.2%	Shares	Sole	2025-08-12
2025-03-31	$8,438,599	10,681,779	-2.4%	Shares	Sole	2025-05-02
2024-12-31	$18,053,606	10,941,582	+4.5%	Shares	Sole	2025-02-07
2024-09-30	$36,656,372	10,473,250	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.